Development of highly potent human monoclonal for RSV immuno-prophylaxis

Ended Project Grant Awarded Last action

Award ID
R44AI136272
Recipient
Awarding agency
Obligated
$2,806,262

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
San Diego, CA 92121, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $947,868
Amendment $801,020
Amendment $58,549
Amendment -$1,175
Original award $1,000,000

Quick answers

Who received award R44AI136272?

R44AI136272 was awarded to Mapp Biopharmaceutical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 2, 2020.

How much is award R44AI136272 worth?

$2,806,262 has been obligated on R44AI136272.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award